Donna ShalalaSell
PBYI · Transaction May 15, 2019 · Filed Apr 27, 2020 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · PBYI
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Puma Biotechnology Inc
Biotechnology
$8.69
Veridion Score
BETAMEDIUM CONF · 5/6 factorsMon Aug 10 · last completed session · Markets closed · resumes Tue 9:30 ET · PBYI
MethodologyPBYI
Puma Biotechnology Inc
Mon Aug 10 · last completed session · Markets closed · resumes Tue 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
67/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Mon Aug 10 · last completed session · Markets closed · resumes Tue 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is PBYI moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Puma Biotechnology Inc
PHARMACEUTICAL PREPARATIONSListed since
2012
Employees
179
Country
US
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$8.69
Last session
Day high
$8.69
Last session
Day low
$8.69
Last session
Previous close
$8.69
52W high
$8.91
-2.47% from high
52W low
$4.34
95% of range
Market cap
$453.5M
P/E
22.87×
EPS
$0.3800
Beta
0.50
Shares out
50.9M
Avg volume
355.1K
VWAP
$8.69
Last session
Price history computed in-house
1W
+11.41%
1M
+8.62%
3M
+21.20%
1Y
+79.18%
YTD
+46.05%
SMA 50 $7.80 · above
SMA 200 $6.68 · above
52W position 95%
PBYI overview
Veridion Score
67
5 of 6 factors measured
Latest receipt rows
5
Donna Shalala · Sale
13F holders
None on file
Related filings and maps
Public disclosures
Congress activity in PBYI
Official filing ↗
PBYI · Transaction Jan 23, 2019 · Filed Apr 27, 2020 · $1,001 to $15,000
Disclosed security · Transaction Sep 26, 2014 · Filed Oct 13, 2014 · $1,001 to $15,000
PBYI · Transaction Sep 10, 2014 · Filed Oct 13, 2014 · $1,001 to $15,000
PBYI · Transaction Jul 30, 2014 · Filed Aug 14, 2014 · $1,001 to $15,000
Federal contracts
PBYI contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PBYI in this window.
Lobbying spend
PBYI lobbying filings, year to date.
Registered lobbying filings matched to Puma Biotechnology Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PBYI in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for PBYI.
Options
Sovereign unlock shows live options positioning for PBYI.